ncRNA name
hsa-miR-504
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
NRF1
Cancer name
Nasopharyngeal Carcinoma
Cancer site
Nasopharynx
Treatment type
Radiotherapy
Impact of wild-type ncRNA on radiotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-504 might become a promising biomarker of NPC radio-resistance and targeting miR-504 might improve tumor radiation response.
Tissue resource
serum samples from nasopharyngeal carcinoma patients
nasopharyngeal carcinoma radio-resistant cell lines CNE2-IR
nasopharyngeal carcinoma radio-resistant cell lines HK1-IR
nasopharyngeal carcinoma cell lines CNE2
nasopharyngeal carcinoma cell lines HK1
Experiment
qRT-PCR,Western blot,Luciferase reporter assay
Institute
Xiangya Hospital, Central South University
Country
China
Continent
Asia